RL Hulett：2025年第四季度全球专科医疗服务行业并购市场研究报告（英文版）

Of the 215 deals in the Specialty Healthcare Services sector in Q4, North America was the most active with 110. A notable North American deal (in addition to the OneOncology deal mentioned on the previous page) was AbbVie’s $1.2B acquisition of Giglamesh Pharmaceuticals, a New York-based developer of a mental health science focused biotechnology platform, in October 2025. Europe was the second most active with 76 transactions and all other regions combined for a total of 29 deals